Workshop 3
Adaptive immunity

Programm

• 16:00 – 16:15 12 Min. 3 Min.

  • Abstract talk
  • O 011

  SARS-CoV-2-specific mucosal immunity reduces infection susceptibility and virus shedding

  • Dr. Benjamin Meyer (Geneva / CH)

   Adaptive immunity
• 16:15 – 16:30 12 Min. 3 Min.

  • Abstract talk
  • O 012

  Elucidating Sterilizing Immunity Mechanisms Provided by an HIV-1 Neutralizing Antibody Against Mucosal Infection in a Non-Human Primate Model

  • Prof. Dr. Klaus Überla (Erlangen / DE)

   Adaptive immunity
• 16:30 – 16:45 12 Min. 3 Min.

  • Abstract talk
  • O 013

  Unveiling Novel Therapeutic Targets for Human Cytomegalovirus (HCMV) Infection: Exploring the Antibody Response to the gH/UL116 Complex

  • Dr. Matthias Zehner (Cologne / DE)

   Adaptive immunity
• 16:45 – 17:00 12 Min. 3 Min.

  • Abstract talk
  • O 014

  Latent Herpes virus infections modulate the function of cytotoxic CD4+ T- Cells and Natural killer cells with antitumor activity

  • Mohamed Saad (Essen / DE)

   Adaptive immunity
• 17:00 – 17:15 12 Min. 3 Min.

  • Abstract talk
  • O 015

  Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition

  • Yin-Han Chou (Hanover / DE)

   Adaptive immunity
• 17:15 – 17:30 12 Min. 3 Min.

  • Abstract talk
  • O 016

  MMP-9 Suppresses the Anti-HBsAg B Cell Response During Chronic HBV Infection

  • Prof. Dr. Jia Liu (Wuhan / CN)

   Adaptive immunity